-U Veronesi Researcher Activity Profile

Research Author Detailed Information 

U Veronesi Publication Rate By Year

U Veronesi has published 1 paper(s) in 1976, 1 paper(s) in 1977, 2 paper(s) in 1978, 1 paper(s) in 1979, 1 paper(s) in 1982, 1 paper(s) in 1984, 1 paper(s) in 1985, 1 paper(s) in 1990, 1 paper(s) in 1993, 1 paper(s) in 1996, 1 paper(s) in 2000, 1 paper(s) in 2003, 2 paper(s) in 2006, 8 paper(s) in 2007, 6 paper(s) in 2008, for a total of 29 research publications in total.

U U Veronesi Author Information

LAST NAME: veronesi

FIRST NAME: U

INITIALS: u

AFFILIATION:

Papers

U Veronesi's Publication Record

1. Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer. Year Published: 2006
European Institute of Oncology, Milan, Italy. umberto.veronesi@ieo.it
2. Sentinel lymph node biopsy in male patients with early breast cancer. Year Published: 2007
Division of Breast Surgery, European Institute of Oncology, 20141, Milan, Italy. oreste.gentilini@ieo.it
3. Is avoiding post-mastectomy radiotherapy justified for patients with four or more involved axillary nodes and endocrine-responsive tumours? Lessons from a series in a single institution. Year Published: 2007
Division of Breast Surgery, European Institue of Oncology, Milan, Italy. oreste.gentilini@ieo.it
4. Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer. Year Published: 2007
Division of Nuclear Medicine, European Institute of Oncology, Milan, Italy. divisione.medicinanucleare@ieo.it
5. Unnecessary axillary node dissections in the sentinel lymph node era. Year Published: 2007
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti, 435, 20141 Milan, Italy.
6. Electron intraoperative treatment in patients with early-stage breast cancer: data update. Year Published: 2006
University of Milan, Radiation Oncology Department, European Institute of Oncology, Via Ripamonti 435 I-20141 Milan, Italy. roberto.orecchia@ieo.it
7. Synthetic retinoid fenretinide in breast cancer chemoprevention. Year Published: 2007
Division of Cancer Prevention and Genetics, European Institute of Oncology, Milano, Italy. bernardo.bonanni@ieo.it
8. Is avoiding post-mastectomy radiotherapy justified for patients with four or more involved axillary nodes and endocrine-responsive tumours? Lessons from a series in a single institution. Year Published: 2007
Division of Breast Surgery, European Institue of Oncology, Milan, Italy. oreste.gentilini@ieo.it
9. Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer. Year Published: 2007
Division of Nuclear Medicine, European Institute of Oncology, Milan, Italy. divisione.medicinanucleare@ieo.it
10. Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer. Year Published: 2008
European Institute of Oncology, Milano, Italy.
11. Unnecessary axillary node dissections in the sentinel lymph node era. Year Published: 2007
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti, 435, 20141 Milan, Italy. mattia.intra@ieo.it
12. Present and future of sentinel node lymphadenectomy in breast cancer. Year Published: 2000
Istituto Europeo di Oncologia, Milan, Italy.
13. HRT opposed to low-dose tamoxifen (HOT study): rationale and design. Year Published: 2003
European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.
14. Adjuvant combination chemotherapy in primary mammary carcinoma: the CMF program. Year Published: 1978
15. Regional lymph node dissection in melanoma of the limbs. Stage I. A cooperative international trial (WHO Collaborating Centers for diagnosis and treatment of melanoma). Year Published: 1978
16. Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report. Year Published: 1979
17. Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: the Milan Institute experience. Year Published: 1982
18. New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan. Year Published: 1984
19. CMF adjuvant programs at the Milan Cancer Institute. Year Published: 1985
20. New trends in breast cancer surgery. Year Published: 1990
Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy.
21. Primary chemotherapy for resectable breast cancer. Year Published: 1993
Istituto Nazionale Tumori, Milan, Italy.
22. The control of breast cancer: a look into the future. Year Published: 1996
European Institute of Oncology, Milan, Italy.
23. Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer. Year Published: 2008
European Institute of Oncology, Milano, Italy.
24. Laparoscopy and laparotomy in staging Hodgkin's and non-Hodgkin's lymphoma. Year Published: 1976
25. New trends in the treatment of breast cancer at the Cancer Institute of Milan. Year Published: 1977
26. Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years. Year Published: 2008
Division of Breast Surgery, European Institute of Oncology, Milan, Italy. mattia.intra@ieo.it
27. Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer. Year Published: 2008
Department of Medical Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori [corrected]
28. When Sentinel Lymph Node is Intramammary. Year Published: 2008
Breast Surgery Department, European Institute of Oncology, Via Ripamonti 435, Milan, MI, 20141, Italy, mattia.intra@ieo.it.
29. When sentinel lymph node is intramammary. Year Published: 2008
Breast Surgery Department, European Institute of Oncology, Via Ripamonti 435, Milan, MI 20141, Italy. mattia.intra@ieo.it